On Tuesday, Sen. Rob Portman said he is participating in Janssen-Johnson & Johnson’s coronavirus vaccine trial.
“After getting briefed on the Janssen-Johnson & Johnson phase 3 trial recently by Cincinnati’s own CTI Clinical Trial and Consulting Services, I decided to step forward and enroll in the trial myself,” Portman said in a statement.
“I look at it as a way I can play a small role in supporting our country’s health care response to this pandemic,” he then mentioned. “The more people Johnson & Johnson has in the trial, the sooner they can have the complete data they need to finalize this phase of the trial, and move on to the FDA approval process.”
He also added that as the country continues to address the ongoing health crisis, “I’ve been encouraged by our progress in developing effective vaccines.”
The 64-year-old senator is enrolled in the ENSEMBLE phase 3 trial at CTI Clinical Trial and Consulting Services’ research center in Cincinnati.
“I hope that my announcement today will encourage others to feel confident in participating in vaccine clinical trials being conducted across this country,” Portman also said. “I also hope it will reassure people about the safety and effectiveness of vaccines once they have gone through the trials and FDA approval process.”
According to Johnson & Johnson, the Phase 3 trial launched on September 23rd.